EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 12 filers reported holding EVOKE PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $14,000 | -44.0% | 28,200 | -38.1% | 0.00% | – |
| Q4 2021 | $25,000 | -94.8% | 45,535 | -75.7% | 0.00% | -100.0% |
| Q4 2020 | $483,000 | +360.0% | 187,276 | +739.8% | 0.00% | – |
| Q3 2020 | $105,000 | +707.7% | 22,300 | +4.0% | 0.00% | – |
| Q2 2019 | $13,000 | -95.2% | 21,442 | -82.1% | 0.00% | – |
| Q3 2016 | $271,000 | +110.1% | 120,000 | +534.9% | 0.00% | – |
| Q2 2016 | $129,000 | +239.5% | 18,900 | +43.2% | 0.00% | – |
| Q3 2015 | $38,000 | -44.1% | 13,200 | +1.4% | 0.00% | – |
| Q2 2015 | $68,000 | – | 13,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 87,925 | $48,000 | 0.01% |
| Wambolt & Associates, LLC | 32,000 | $18,000 | 0.01% |
| Virtu Financial LLC | 55,336 | $31,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 183 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $23,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,828 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 210,102 | $117,000 | 0.00% |
| STATE STREET CORP | 72,800 | $41,000 | 0.00% |
| MORGAN STANLEY | 9,606 | $5,000 | 0.00% |